
Vector Laboratories
Life science reagents company founded in 1976, owner of LSBio, Absolute Biotech, Quanta BioDesign, and other research brands, backed by Thompson Street Capital Partners.
Company Type
private
Founded
1976
Headquarters
Newark, California, United States
Primary Market
Global
Vector Laboratories Timeline
Shop Vector Laboratories Brands
Disclosure: We may earn commission from purchasesAbout Vector Laboratories
What does Vector Laboratories own?
The company operates a brand portfolio that includes its core Vector reagent lines, LSBio (antibodies and assays), Absolute Biotech, and Quanta BioDesign (PEG chemistry), assembled through its buy-and-build strategy since 2015.
Is Vector Laboratories publicly traded?
No. Vector Laboratories is privately held by private equity firm Thompson Street Capital Partners, which acquired a majority stake in 2015. It has no stock listing.
Who founded Vector Laboratories?
Jim Whitehead founded the company in 1976 in Burlingame, California, commercializing avidin-biotin detection chemistry for immunohistochemistry. The company relocated to Newark, California, where it is still based.
Where is Vector Laboratories headquartered?
The company's headquarters and primary manufacturing site is at 30 Ingold Road, Newark, California, in the East Bay. It operates additional sites in Seattle, San Diego, Atlanta, Absam (Austria), and the UK through its brands.
How many brands does Vector Laboratories own?
Four principal brands: Vector Laboratories core reagents, LSBio, Absolute Biotech, and Quanta BioDesign, plus associated product families such as ImmPACT substrates.
Who owns Vector Laboratories?
Thompson Street Capital Partners, a St. Louis private equity firm, holds the controlling stake acquired in 2015. Management and prior owners may retain minority positions; the company does not disclose its cap table.
History of Vector Laboratories
Jim Whitehead, a researcher frustrated by the lack of sensitive detection reagents for microscopy, founded Vector Laboratories in 1976 in Burlingame, California. His innovation was commercializing avidin-biotin detection chemistry, which dramatically improved the sensitivity of immunohistochemistry and in situ hybridization, and the company became a standard supplier in pathology and research labs.
For decades Vector operated as a founder-led reagent company, expanding from its original detection kits into lectins, enzyme substrates, and labeling reagents. The company relocated to Newark, California, in the East Bay, building manufacturing and R&D facilities to support global distribution.
In 2015 private equity firm Thompson Street Capital Partners acquired a majority stake, beginning the platform era. Under TSCP, Vector added complementary businesses: Seattle-based LifeSpan BioSciences (LSBio) in 2018 for its antibody and assay catalog; antibody platform Absolute Biotech, which merged into the Vector organization in 2024; and PEG reagent maker Quanta BioDesign.
Lisa Sellers, who joined from PerkinElmer where she ran its global laboratory business, was appointed CEO in 2021. Under her leadership the company has consolidated its acquired brands, expanded manufacturing, and positioned the portfolio toward biopharma and diagnostic OEM customers, while retaining the research catalog business that built its reputation.
Vector Laboratories Sustainability & Ethics
As a private reagent manufacturer, Vector's public sustainability footprint is limited to product-level compliance: ISO-certified manufacturing, responsible sourcing of biological materials, and regulatory adherence across research-use-only and diagnostic-grade products. The company maintains quality systems required for biopharma and diagnostic customers.
The company's products support biomedical research broadly, including disease diagnostics and drug development, which constitutes its primary societal contribution. It holds no B Corp or independent ESG certifications.
Brands Owned by Vector Laboratories
Vector Laboratories owns 1 brand in our database. Explore the ownership tree below — click categories to expand and see individual brands.
Vector Laboratories
private · Founded 1976 · Newark, California, United States
1
brands
Vector Laboratories Ownership: Pros & Cons
Advantages
- +Nearly 50 years of brand equity in research reagents
- +Consumable reorder model produces stable recurring revenue
- +Multi-brand portfolio serves distinct customer segments
- +Private equity backing funds continued bolt-on acquisitions
- +High switching costs protect installed customer base
Considerations
- -Competes against giants with far larger catalogs and sales forces
- -Acquisition integration across brands and sites carries execution risk
- -Private equity ownership creates eventual exit pressure
- -Research funding cycles, especially NIH budgets, swing customer demand
- -Concentration in reagents exposes it to platform shifts toward in-house tools
Frequently Asked Questions About Vector Laboratories
What does Vector Laboratories own?
The company operates a brand portfolio that includes its core Vector reagent lines, LSBio (antibodies and assays), Absolute Biotech, and Quanta BioDesign (PEG chemistry), assembled through its buy-and-build strategy since 2015.
Is Vector Laboratories publicly traded?
No. Vector Laboratories is privately held by private equity firm Thompson Street Capital Partners, which acquired a majority stake in 2015. It has no stock listing.
Who founded Vector Laboratories?
Jim Whitehead founded the company in 1976 in Burlingame, California, commercializing avidin-biotin detection chemistry for immunohistochemistry. The company relocated to Newark, California, where it is still based.
Where is Vector Laboratories headquartered?
The company's headquarters and primary manufacturing site is at 30 Ingold Road, Newark, California, in the East Bay. It operates additional sites in Seattle, San Diego, Atlanta, Absam (Austria), and the UK through its brands.
How many brands does Vector Laboratories own?
Four principal brands: Vector Laboratories core reagents, LSBio, Absolute Biotech, and Quanta BioDesign, plus associated product families such as ImmPACT substrates.
Who owns Vector Laboratories?
Thompson Street Capital Partners, a St. Louis private equity firm, holds the controlling stake acquired in 2015. Management and prior owners may retain minority positions; the company does not disclose its cap table.








